Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Glycopyrronium 25 mcg + Formoterol Fumarate 6 mcg
Therapeutic Category
Pulmonary, Respiratory, Asthma
Dosage Form
Rota cap
Packaging Type
in a bottle with carton
Packaging
30 Capsules
Price
₹1/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Glycopryl F is a specialized inhalation medication designed for the effective management of chronic obstructive pulmonary disease (COPD). Each Rota Cap contains a precise combination of Glycopyrronium (25 mcg) and Formoterol Fumarate (6 mcg), which work synergistically to provide long-lasting relief from respiratory symptoms.
Glycopyrronium is an anticholinergic agent that helps to relax and open the airways by blocking the action of acetylcholine, a neurotransmitter that can cause bronchoconstriction. This action leads to improved airflow and reduced breathlessness. Formoterol Fumarate, a long-acting beta-agonist (LABA), complements this effect by stimulating beta-2 adrenergic receptors in the lungs, resulting in further bronchodilation. Together, these components help to alleviate symptoms such as wheezing, coughing, and shortness of breath, enhancing the quality of life for individuals with COPD.
Common side effects may include dry mouth, headache, dizziness, and palpitations. Some patients may experience throat irritation or cough. It is important to monitor for any unusual or severe reactions.
Glycopryl F is indicated for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults.
Glycopryl F should be used only as directed by a healthcare professional. Do not exceed the recommended dosage, and consult a doctor if symptoms persist or worsen.
Store Glycopryl F in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children to ensure safety.
Composition : Glycopyrrolate (25mcg) Respule
Composition : Glycopyrrolate IP 50mcg Rota Capsule
Composition : Glycopyrronium (25mcg) + Formoterol (12mcg)+ Budesonide (400 mcg) Rota Capsule
Composition : Tiotropium (18mcg) Rotacaps
Composition : Budesonide (0.5mg) Respule
Composition : Budesonide (200mcg) + Formoterol (6mcg) Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (200mcg) Inhaler
Composition : Formoterol 6mcg + Budesonide 400mcg Rota Capsule
Composition : Formoterol (6mcg) + Budesonide (400mcg) Inhaler
Composition : Formoterol (20mcg) + Budesonide (0.5mg) Respule
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
This combination has strong demand in the respiratory and pulmonary care segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on COPD and chronic airway disease management portfolios.
Medical distributors and agencies can benefit from consistent demand for long-term maintenance therapy in COPD and chronic bronchial conditions. Glycopyrronium (25 mcg) is a long-acting muscarinic antagonist (LAMA) that helps relax airway muscles and improve airflow Formoterol fumarate (6 mcg) is a long-acting beta-agonist (LABA) that helps reduce bronchospasm and improve breathing This dual bronchodilator combination supports effective long-term respiratory management.
Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Glycopyrronium + Formoterol Rota Cap with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.
Wholesalers and medical agencies benefit from strong pulmonologist prescriptions, chronic COPD patient demand, daily long-term usage, hospital and clinic supply opportunities, reliable supply chain support, and good margins in respiratory medicines.
Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.